華顯光電(00334.HK)首季營業額按年跌1.3%
華顯光電(00334.HK)公佈,今年3月底止首季營業額錄得14.13億元人民幣,按年下跌1.3%。
期內銷量達到1,650萬片,按年下跌7.6%。期內,銷售類模組銷量爲1,580萬片,按年下降6.1%, 佔集團總銷量95.6%。
公司表示,全球疫情預期於上半年持續蔓延,國內個別地區疫情近月更創新高,或會影響國內市場上遊原材料供應及整體消費需求,未來將密切留意市場走勢,積極規劃手機、車載、商用筆電、物聯網相關產品的銷售策略。
華顯光電又預期,隨着位於惠州陳江新廠房將於第二季開始試營運,冀望通過提高技術及規模經濟,依靠與一線手機廠商的長期戰略合作夥伴關係,捕捉海外新興市場所帶來的商機,對顯示模組業務的長遠發展前景持樂觀態度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.